August 22, 2022 – QuidelOrtho Corporation announced today that it is joining the Alliance for a Strong Blood Supply (the “Alliance”). The Alliance is a coalition founded by the Association for the Advancement of Blood & Biotherapies (“AABB”) that includes a group of partner organizations committed to ensuring sufficient blood is available for all patients during the pandemic and beyond.
Regions throughout the United States are currently facing significant blood supply challenges, with many blood collectors operating with less than a one-day supply on hand. Many hospitals have been forced to delay life-saving blood transfusions. The Alliance facilitates communications between member organizations, serves as a platform for member organizations to mobilize their networks, and acts as a forum for members to educate one another on challenges and opportunities to strengthen the national blood supply.
The Alliance currently includes 25 organizations that collectively represent the nation’s hospitals and blood collectors, as well as more than 200,000 physicians who routinely provide blood to patients in need. In addition to QuidelOrtho, current members include: AABB, America’s Blood Centers, Alliance for Community Transfusion Services, American Red Cross, American Society of Anesthesiologists, American Society for Clinical Pathology, American Society for Apheresis, American Society of Hematology, American Society for Transplantation and Cellular Therapy, Blood Centers of America, Blood Centers of California, College of American Pathologists, Cerus, Fresenius Kabi, Lifesouth Community Blood Centers, Macopharma, MediOps, Miller-Keystone Blood Center, Oklahoma Blood Institute, Terumo, UChicago Medicine and University Blood Initiative.
In addition to joining the Alliance, QuidelOrtho is committed to the development and implementation of continuing education in transfusion medicine for its international audience, providing science and educational offerings at the global and regional levels. Recent educational programs conducted by the Ortho Clinical Diagnostics business included more than 20 webinars each year for laboratory clinicians and healthcare professionals in the transfusion medicine community, a monthly podcast and periodic white papers on topics of interest and areas of change in the industry.